These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 20540635

  • 1. Effects of atorvastatin versus probucol on low-density lipoprotein subtype distribution and renal function in hyperlipidemic patients with nondiabetic nephropathy.
    Yasuda G, Ando D, Hirawa N, Umemura S.
    Ren Fail; 2010 Jul; 32(6):680-6. PubMed ID: 20540635
    [Abstract] [Full Text] [Related]

  • 2. Atorvastatin: a new agent for hyperlipidemia.
    Kupecz D.
    Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876
    [No Abstract] [Full Text] [Related]

  • 3. Beneficial effects of atorvastatin in the treatment of hyperlipidemia after renal transplantation.
    Demetriou D, Shabpar A, Böhmig G, Schmaldienst S, Hörl WH, Watschinger B.
    Wien Klin Wochenschr; 2000 Apr 21; 112(8):358-61. PubMed ID: 10849941
    [Abstract] [Full Text] [Related]

  • 4. Qualitative effect of fenofibrate and quantitative effect of atorvastatin on LDL profile in combined hyperlipidemia with dense LDL.
    Winkler K, Weltzien P, Friedrich I, Schmitz H, Nickell HH, Hauck P, Hoffmann MM, Baumstark MW, Wieland H, März W.
    Exp Clin Endocrinol Diabetes; 2004 May 21; 112(5):241-7. PubMed ID: 15146369
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
    Kuryata OV, Yegorova YV.
    Kardiol Pol; 2006 Jan 21; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
    [Abstract] [Full Text] [Related]

  • 7. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.
    Goicoechea M, de Vinuesa SG, Lahera V, Cachofeiro V, Gómez-Campderá F, Vega A, Abad S, Luño J.
    J Am Soc Nephrol; 2006 Dec 21; 17(12 Suppl 3):S231-5. PubMed ID: 17130267
    [Abstract] [Full Text] [Related]

  • 8. [Evaluation of the efficacy of statin therapy in dyslipidemic diseases such as combined hypercholesterolemia IIA and hyperlipidemia].
    Liguori E, Sarcinella R.
    Minerva Cardioangiol; 1998 Sep 21; 46(9):317-8. PubMed ID: 10021861
    [No Abstract] [Full Text] [Related]

  • 9. Effect of atorvastatin on low-density lipoprotein subtypes in patients with different forms of hyperlipoproteinemia and control subjects.
    Geiss HC, Otto C, Schwandt P, Parhofer KG.
    Metabolism; 2001 Aug 21; 50(8):983-8. PubMed ID: 11474489
    [Abstract] [Full Text] [Related]

  • 10. Effect of atorvastatin on type 2 diabetic dyslipidemia.
    Save V, Patil N, Moulik N, Rajadhyaksha G.
    J Cardiovasc Pharmacol Ther; 2006 Dec 21; 11(4):262-70. PubMed ID: 17220473
    [Abstract] [Full Text] [Related]

  • 11. Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
    Robinson JG, Davidson MH.
    Expert Rev Cardiovasc Ther; 2006 Jul 21; 4(4):461-76. PubMed ID: 16918265
    [Abstract] [Full Text] [Related]

  • 12. HMG-CoA reductase inhibitors and renal function.
    Campese VM, Park J.
    Clin J Am Soc Nephrol; 2007 Nov 21; 2(6):1100-3. PubMed ID: 17942762
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation.
    Wissing KM, Unger P, Ghisdal L, Broeders N, Berkenboom G, Carpentier Y, Abramowicz D.
    Transplantation; 2006 Sep 27; 82(6):771-8. PubMed ID: 17006324
    [Abstract] [Full Text] [Related]

  • 17. Treating to meet NCEP-recommended LDL cholesterol concentrations with atorvastatin, fluvastatin, lovastatin, or simvastatin in patients with risk factors for coronary heart disease.
    Hunninghake D, Bakker-Arkema RG, Wigand JP, Drehobl M, Schrott H, Early JL, Abdallah P, McBride S, Black DM.
    J Fam Pract; 1998 Nov 27; 47(5):349-56. PubMed ID: 9834769
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.